➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Last Updated: July 24, 2021

DrugPatentWatch Database Preview

Patent: 5,457,093

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 5,457,093
Title: Gel formulations containing growth factors
Abstract:Gel formulations containing polypeptide growth factors having human mitogenic or angiogenic activity are provided. The gel formulations are useful for topical or incisional wound healing for cutaneous wounds, in the anterior chamber of the eye and other ophthalmic wound healing. The gel formulations also comprise a water soluble, pharmaceutically or ophthalmically compatible polymeric material for providing viscosity within various ranges determined by the application of the gel. The gel formulations provide controlled release and increased contact time of the growth factor to the wound site.
Inventor(s): Cini; John K. (Bethlehem, PA), Finkenaur; Amy L. (Neshanic Station, NJ)
Assignee: Ethicon, Inc. (Somerville, NJ)
Application Number:08/135,230
Patent Claims:see list of patent claims

Details for Patent 5,457,093

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Smith And Nephew REGRANEX becaplermin GEL; TOPICAL 103691 001 1997-12-16 ⤷  Free Forever Trial Ethicon, Inc. (Somerville, NJ) 2012-10-10 RX company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 5,457,093

Country Patent Number Estimated Expiration
South Africa 886947 ⤷  Free Forever Trial
South Africa 968398 ⤷  Free Forever Trial
World Intellectual Property Organization (WIPO) 9712601 ⤷  Free Forever Trial
United States of America 5427778 ⤷  Free Forever Trial
United States of America 5705485 ⤷  Free Forever Trial
Portugal 859596 ⤷  Free Forever Trial
Portugal 88541 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.